Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(10)
•••
Comment by ttboy29on May 16, 2018 10:13am
62 Views
Post# 28038508

RE:Isol listed as top five potstock of 2018...

RE:Isol listed as top five potstock of 2018...

Global Bioactive CBD oil company Isodiol International Inc. (CSE:ISOL) (ISOLF) announced this year the acquisition of several global assets, making them one of 2018’s top marijuana stocks in the industry. The company has begun to develop a new facility in China where they plan to take certified organic hemp and extract cannabinoids and terpenes.

Isodiol’s new strategic assets in the U.K., Brazil, and China may help the company attain global dominance in the growing CBD oil sector. In fact, as once noted on this site, they are, “a pot stock so steeped in extracts that CBD oil stock seems the more appropriate term.”

“These transactions mark major milestones for Isodiol. The acquisitions ensure the company has a continued source of CBD and scalability of production as our international expansion continues to generate additional market demand for our products,” remarked CEO Marcos Agramont. Isodiol is making some of the best moves in the market today.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities